Hancock Whitney Corp Moderna, Inc. Transaction History

Hancock Whitney Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $2.41 Million - $3.17 Million	-25,044 Closed	0 $0
Q2 2023 Nov 13, 2023	SELL	$118.5 - $160.53 $595,462 - $806,663	-5,025 Reduced 16.71%	25,044 $3.04 Million
Q2 2023 Aug 10, 2023	SELL	$118.5 - $160.53 $595,462 - $806,663	-5,025 Reduced 16.71%	25,044 $3.04 Million
Q1 2023 Nov 13, 2023	SELL	$135.66 - $197.02 $230,486 - $334,736	-1,699 Reduced 5.35%	30,069 $4.62 Million
Q1 2023 May 16, 2023	SELL	$135.66 - $197.02 $230,486 - $334,736	-1,699 Reduced 5.35%	30,069 $4.62 Million
Q4 2022 Nov 13, 2023	BUY	$118.38 - $210.04 $795,987 - $1.41 Million	6,724 Added 26.85%	31,768 $5.71 Million
Q4 2022 Feb 03, 2023	BUY	$118.38 - $210.04 $84,878 - $150,598	717 Added 2.31%	31,768 $5.71 Million
Q3 2022 Oct 26, 2022	BUY	$118.07 - $194.18 $3.67 Million - $6.03 Million	31,051 New	31,051 $3.67 Million

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.